✦ LIBER ✦

Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

✍ Scribed by G Missale; E Cariani; V Lamonaca; A Ravaggi; A Rossini; R Bertoni; M Houghton; Y Matsuura; T Miyamura; F Fiaccadori; C Ferrari

Book ID: 118686682
Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 220 KB
Volume: 26
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.1997.v26.pm0009303515

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of interferon treatment on the a

Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients

✍ G Missale; E Cariani; V Lamonaca; A Ravaggi; A Rossini; R Bertoni; M Houghton; Y 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 3 views

The viral genotype may influence the response to interferon sion and more efficient antiviral immune response, is still (IFN) treatment in chronic hepatitis C virus (HCV) infection. unclear. To characterize potential mechanisms responsible for this ef-Several factors including viral load, disease se

Effect of treatment with interferon α-2b

Effect of treatment with interferon α-2b and ribavirin in patients infected with genotype 2 hepatitis C virus

✍ Yoshihiko Nagase; Hiroshi Yotsuyanagi; Chiaki Okuse; Kiyomi Yasuda; Tomohiro Kat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

Antiviral activity of the hepatitis C vi

Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir in genotype 1–infected patients

✍ Frank Wagner; Robert Thompson; Constantino Kantaridis; Paul Simpson; Philip J. F 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

More effective and better-tolerated therapies are needed for chronic hepatitis C virus (HCV) infection. Among the direct-acting anti-HCV agents in development is the nonstructural 5B protein (NS5B polymerase) non-nucleoside inhibitor filibuvir. We investigated the antiviral activity, pharmacokinetic

GNB3 C825T polymorphism and response to

GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection

✍ Christoph Sarrazin; Thomas Berg; Viola Weich; Tobias Mueller; Ulrich H. Frey; St 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 111 KB

High-Dose Interferon-α2b Plus Ribavirin

High-Dose Interferon-α2b Plus Ribavirin for Retreatment of Interferon-Nonresponsive Patients Infected with Genotype 1 Hepatitis C Virus

✍ Maria Buti; Sergio Morral; Francisco Sanchez; Maria Martell; Carlos Stalgis; R. 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 68 KB

Response to long-term lamivudine treatme

Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C

✍ Mariko Kobayashi; Fumitaka Suzuki; Norio Akuta; Yoshiyuki Suzuki; Yasuji Arase; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

## Abstract Response to lamivudine treatment longer than 1 year was compared in 15 patients persistently infected with hepatitis B virus (HBV) genotype A, 38 with genotype B, and 449 with genotype C. Patients with genotype A were younger (median age 37 [range 24–49] vs. 47 [24–67] or 44 [18–73], __